Vinati Organics Ltd

- Vinati Organics Limited does not plan to raise any debt for current or future projects. - All future projects, including the PAP project, are expected to be funded entirely through internal accruals. - The company currently has no debt on the books. - Management aims to maintain a payout ratio of about 20%, reinvesting most cash flows back into the business to maximize returns. - Cash flows for the current year are expected to be around Rs.400 Crores on Rs.1000 Crores revenues, indicating strong internal funding capability.

- **ATBS Capacity Expansion:** Increasing from 26,000 to 40,000 tonnes; capex of Rs. 75-80 Crores, expected completion by April 2019. - **Butylphenol Plant:** Investment of Rs. 240 Crores, expecting sales of Rs. 350-400 Crores; plant to come on stream by April 2019, ramping up to 65% utilization in first year and 100% subsequently. - **PAP Project:** Pilot plant with Rs. 20 Crores investment; commercial decision pending successful pilot trials over next 3-6 months; potential major future project with estimated Rs. 600 Crores capex, 1:1 asset turnover, and 20% EBITDA margins. - **Overall Capex Guidance:** Rs. 300 Crores for FY2019 mainly for butylphenols and ATBS expansion; FY2020 capex uncertain, dependent on PAP project. - **Funding:** All future projects to be funded through internal accruals without additional debt; payout ratio maintained around 20%.

- Vinati Organics expects profits to grow at 25%-30% annually over the next three years. - EBITDA margins are anticipated to sustain around 35%, supported by high-margin ATBS volumes and stable product mix. - The company projects a 25% volume growth in ATBS for the next two to three years due to increased capacity and market leadership. - Butylphenol plant commissioning in April 2019 will ramp up sales to Rs.350-400 Crores, achieving 60%-65% capacity utilization in FY2020 and full utilization by FY2021. - IBB volumes are expected to grow approximately 15% annually from FY2020, recovering from prior customer shutdowns and capacity expansion. - PAP project is uncertain; management advises excluding PAP from near-term projections. - Overall, business growth driven by existing products with new capacities and expansions support a robust earnings growth outlook.

- The transcript does not explicitly mention the current or expected order book or pending orders for Vinati Organics Limited. - However, the company has highlighted strong demand and capacity utilization: - ATBS capacity is fully utilized at 26,000 tonnes with plans to expand to 40,000 tonnes by April 2019 due to strong market demand and exit of competitor Lubrizol. - IBB capacity has been expanded from 16,000 to 25,000 tonnes, catering to growing demand. - The butylphenol plant is expected to start by April 2019 with ramp-up over FY2020 and FY2021. - The company expects growth driven by volume growth in ATBS and new customer additions. - Capex plans include Rs. 75-80 Crores for ATBS expansion and Rs. 240 Crores for butylphenol plant. - No specific order book figures or pending order details were provided in the call.

- Vinati Organics expects overall sales growth at a CAGR of ~25% for the next 3 years. - ATBS volumes are projected to grow by 25%-30% annually for the next 2-3 years, driven by capacity expansion from 26,000 to 40,000 tonnes by April 2019. - Butylphenols plant to start by April 2019 with 60-65% capacity utilization in FY2020 and full utilization in FY2021, targeting Rs.350-400 Crores in sales. - IBB volumes expected to grow around 15% in FY2020 after subdued growth in FY2019 due to customer shutdown. - PAP project’s commercialization is uncertain; management excludes it from near-term projections. - Continued focus on new products backed by R&D pipeline to sustain long-term growth.